HPV vaccine and Gardasil 9 in NYC

Gardasil 9 is FDA-approved for people ages 9 through 45. CDC recommends routine HPV vaccination at ages 11 or 12, allows a start at age 9, and recommends catch-up vaccination through age 26. Some adults ages 27 through 45 may choose vaccination after a clinician discussion. The vaccine prevents new HPV infections; it does not treat an infection or HPV-related disease that is already present.

The short answer

Current guidance checked August 1, 2026

Gardasil 9 is FDA-approved for people ages 9 through 45. CDC recommends routine HPV vaccination at ages 11 or 12, allows a start at age 9, and recommends catch-up vaccination through age 26. Some adults ages 27 through 45 may choose vaccination after a clinician discussion. The vaccine prevents new HPV infections; it does not treat an infection or HPV-related disease that is already present.

Eligibility and timing

The clinician applies current guidance to the person, prior doses, and purpose of vaccination.

Who may qualify

Routine vaccination is recommended at ages 11 or 12 and can begin at age 9.
Catch-up vaccination is recommended through age 26 when the series is incomplete.
For ages 27 through 45, the decision is individualized rather than a routine recommendation.
HPV testing is not required to decide whether to vaccinate, but vaccination does not replace cervical screening.

Schedule and timing

Most people who start before age 15 receive two doses 6 to 12 months apart.
People who start at age 15 or older usually receive three doses at 0, 1 to 2, and 6 months.
Immunocompromised people ages 9 through 26 generally receive a three-dose series.
CDC advises delaying remaining HPV vaccine doses until after pregnancy; pregnancy testing is not required first.

What happens at the visit

Book a vaccine review

Choose the general vaccine appointment. Booking starts a clinical review and does not reserve a product.

Bring records and details

Bring dose dates, product names, allergies, medicines, prior reactions, and an itinerary when travel is relevant.

Confirm eligibility and access

The clinician confirms the current indication, timing, product, inventory, certification, and site capability.

Plan the next dose

If vaccination is appropriate and available, the care team documents the dose and explains follow-up or series timing.

When to pause the visit or get urgent help

Tell the clinician about a severe allergy after an earlier HPV vaccine dose or to a vaccine component, current pregnancy, moderate or severe illness, and any prior fainting after shots. Soreness, redness, headache, or brief fever can occur. Call 911 for trouble breathing, facial or throat swelling, widespread hives, collapse, or another sign of a severe allergic reaction.

Cost, records, and access

Insurance and cost

Coverage depends on age, plan rules, network status, and the visit setting. Ask the insurer about HPV vaccine benefits and any cost sharing. Nao Medical must confirm the expected charge, product inventory, and clinic capability before vaccination.

Verified access

The cards below identify vaccine-review starting points only. They do not show live Gardasil 9 stock. The care team must confirm age and indication, the required dose, inventory, and the site that can administer and document the vaccine.

Choose a vaccine-review starting point

Appointment times vary. Confirm the product, eligibility, inventory, certification, and clinic capability before travel to a location.